Israeli biotech firm to test radiation therapy in Fukushima

JERUSALEM, Dec 3 (Reuters) - Israeli biotech firm Pluristem Therapeutics has partnered with Japan's Fukushima Medical University to test its radiation treatment derived from human placenta cells, which it hopes will protect workers decommissioning nuclear reactors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.